|
A 69-year-old female patient with newly diagnosed glioblastoma (gbm) began optune gio therapy on (b)(6) 2023.On (b)(6) 2026, novocure received a medical record dated on (b)(6) 2026, indicating that the patient continued to use optune gio regularly but experienced skin irritation.The record noted that the patient was using a protective barrier product and prescribed hydroxyzine 10 mg to manage itching, as well as clobetasol 0.05% and mupirocin 2% ointments.The healthcare provider also recommended intermittent periods of scalp rest.On june 08, 2026, the prescribing physician reported they were not aware of the reported issue.
|